BIODESIX, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
BIODESIX, INC. (BDSX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $289.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $230.00K.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $59.00K, a 31.11% increase year-over-year.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was -$88.00K, a 129.14% decline year-over-year.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $687.00K.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $644.00K, a 10.46% increase from fiscal 2024.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $583.00K, a 26.85% decline from fiscal 2023.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $797.00K, a 79.75% decline from fiscal 2022.
- BIODESIX, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $3.94M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $289.00K 10-Q · filed 2026-08-05 | $201.00K derived: sum of 3 quarters · filed 2026-08-05 | $888.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $59.00K 10-Q · filed 2026-05-04 | -$29.00K derived: sum of 2 quarters · filed 2026-05-04 | $658.00K derived: sum of 3 quarters · filed 2026-05-04 | $658.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $599.00K derived: sum of 2 quarters · filed 2026-02-26 | $599.00K derived: sum of 3 quarters · filed 2026-08-05 | $644.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $687.00K derived: sum of 2 quarters · filed 2026-08-05 | $732.00K 10-Q · filed 2025-11-03 | $1.03M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $45.00K 10-Q · filed 2026-08-05 | $347.00K derived: sum of 3 quarters · filed 2026-08-05 | $347.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $45.00K 10-Q · filed 2026-05-04 | $347.00K derived: sum of 2 quarters · filed 2026-05-04 | $347.00K derived: sum of 3 quarters · filed 2026-05-04 | $290.00K derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $302.00K derived: sum of 2 quarters · filed 2026-02-26 | $245.00K derived: sum of 3 quarters · filed 2026-02-26 | $583.00K 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$57.00K derived: sum of 2 quarters · filed 2025-11-03 | $281.00K 10-Q · filed 2025-11-03 | $211.00K derived: sum of 4 quarters · filed 2025-11-03 | |||
| 2024-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $281.00K 10-Q · filed 2025-08-07 | $211.00K derived: sum of 3 quarters · filed 2025-08-07 | $220.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $338.00K 10-Q · filed 2025-05-13 | $268.00K derived: sum of 2 quarters · filed 2025-05-13 | $277.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.09M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$61.00K derived: sum of 2 quarters · filed 2025-03-03 | $754.00K derived: sum of 3 quarters · filed 2025-03-03 | $797.00K 10-K · filed 2025-03-03 | |||
| 2023-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $824.00K derived: sum of 2 quarters · filed 2024-11-01 | $867.00K 10-Q · filed 2024-11-01 | $1.11M derived: sum of 4 quarters · filed 2024-11-01 | |||
| 2023-06-30 | $815.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $858.00K 10-Q · filed 2024-08-07 | $1.10M derived: sum of 3 quarters · filed 2024-08-07 | $1.39M derived: sum of 4 quarters · filed 2024-08-07 | |||
| 2023-03-31 | $43.00K 10-Q · filed 2024-05-08 | $285.00K derived: sum of 2 quarters · filed 2024-05-08 | $576.00K derived: sum of 3 quarters · filed 2024-05-08 | $2.75M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $533.00K derived: sum of 2 quarters · filed 2024-03-01 | $2.71M derived: sum of 3 quarters · filed 2024-03-01 | $3.94M 10-K · filed 2024-03-01 | |||
| 2022-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.47M derived: sum of 2 quarters · filed 2023-11-07 | $3.69M 10-Q · filed 2023-11-07 | $4.96M 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $3.40M 10-Q · filed 2023-08-07 | $4.67M 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | $1.23M 10-Q · filed 2023-05-11 | $2.50M 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |